Stereotactic MR-Guided On-Table Adaptive Radiation Therapy (SMART) for Patients with Borderline or Locally Advanced Pancreatic Cancer: Primary Endpoint Outcomes of a Prospective Phase II Multi-Center International Trial

被引：0

作者：

Parikh, P. J. ^{[1
]}

Lee, P. ^{[2
]}

Low, D. ^{[3
]}

Kim, J. ^{[1
]}

Mittauer, K. E. ^{[4
]}

Bassetti, M. F. ^{[5
]}

Glide-Hurst, C. ^{[5
]}

Raldow, A. ^{[6
]}

Yang, Y. ^{[6
]}

Portelance, L. ^{[7
]}

Zaki, B. ^{[8
]}

Kim, H. ^{[9
]}

Mancias, J. D. ^{[10
]}

Ng, J. ^{[11
]}

Pfeffer, R. M. ^{[12
]}

Mueller, A. ^{[13
]}

Kelly, P. ^{[14
]}

Boldrini, L. ^{[15
]}

Fuss, M., Jr. ^{[16
]}

Chuong, M. D. ^{[17
]}

机构：

[1] Henry Ford Canc Inst, Dept Radiat Oncol, Detroit, MI USA

[2] City Hope Natl Med Ctr, Los Angeles, CA USA

[3] Univ Calif Los Angeles, Dept Radiat Oncol, Los Angeles, CA 90024 USA

[4] Baptist Hlth South Florida, Miami Canc Inst, Dept Radiat Oncol, Miami, FL USA

[5] Univ Wisconsin, Carbone Canc Ctr, Dept Human Oncol, Madison, WI USA

[6] Univ Calif Los Angeles, David Geffen Sch Med, Dept Radiat Oncol, Los Angeles, CA 90095 USA

[7] Miller Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL USA

[8] Dartmouth Hitchcock Med Ctr, Hanover, NH USA

[9] Washington Univ, Sch Med, Dept Radiat Oncol, St Louis, MO USA

[10] Harvard Med Sch, Dept Radiat Oncol, Dana Farber Canc Inst, Dept Radiat Oncol,Brigham & Womens Hosp, Boston, MA 02115 USA

[11] Weill Cornell Med, Dept Radiat Oncol, New York, NY USA

[12] Assuta Med Ctr, Tel Aviv, Israel

[13] Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Dept Radiat Oncol, Philadelphia, PA 19107 USA

[14] Orlando Hlth Canc Inst, Dept Radiat Oncol, Orlando, FL USA

[15] Fdn Policlin Univ A Gemelli IRCCS, Dept Radiol Radiat Oncol & Hematol, Rome, Italy

[16] ViewRay Inc, Mountain View, CA USA

[17] Miami Canc Inst, Dept Radiat Oncol, Miami, FL USA

来源：

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2022年 / 114卷 / 05期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

LBA 09

引用

页码：1062 / 1063

页数：2

共 50 条

[31] Results of a prospective phase 2 clinical trial of induction gemcitabine/capecitabine followed by stereotactic ablative radiation therapy in borderline resectable or locally advanced pancreatic adenocarcinoma
Quan, Kimmen
Sutera, Philip
Xu, Karen
Bernard, Mark E.
Burton, Steven A.
Wegner, Rodney E.
Zeh, Herbert
Bahary, Nathan
Stoller, Ronald
Heron, Dwight E.
PRACTICAL RADIATION ONCOLOGY, 2018, 8 (02) : 95 - 106
[32] Stereotactic ultrahypofractionated MR-guided radiotherapy for localized prostate cancer - Acute toxicity and patient-reported outcomes in the prospective, multicenter SMILE phase II trial
Fink, C. A.
Ristau, J.
Buchele, C.
Klueter, S.
Liermann, J.
Hoegen-Sassmannshausen, P.
Sandrini, E.
Lentz-Hommertgen, A.
Baumann, L.
Andratschke, N.
Baumgartl, M.
Li, M.
Reiner, M.
Corradini, S.
Hoerner-Rieber, J. Ho
Bonekamp, D.
Schlemmer, H. -P.
Belka, C.
Guckenberger, M.
Debus, J.
Koerber, S. A.
CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2024, 46
[33] Prospective Phase I Trial of Concurrent Full Dose Gemcitabine/Nab-paclitaxel and Ablative Radiation Therapy for Borderline and Locally Advanced Pancreatic Cancer
Kim, H.
Olsen, J. R.
Wang-Gillam, A.
Green, O. L.
Fields, R. C.
Hammill, C.
Strasberg, S.
Doyle, M. B.
Hawkins, W.
Suresh, R.
Tan, B.
Pedersen, K.
Henke, L. E.
DeWees, T. A.
Chapman, W.
Parikh, P. J.
Roach, M. C., Jr.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : S209 - S210
[34] High neutrophil-to-lymphocyte ratio following stereotactic body radiation therapy is associated with poor clinical outcomes in patients with borderline resectable and locally advanced pancreatic cancer
Reddy, Abhinav, V
Hill, Colin S.
Sehgal, Shuchi
He, Jin
Zheng, Lei
Herman, Joseph M.
Meyer, Jeffrey
Narang, Amol K.
JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2022, 13 (01) : 368 - +
[35] Sequential treatment with gemcitabine/nab-paclitaxel (GA) and FOLFIRINOX (FFX) followed by stereotactic MRI-guided adaptive radiation therapy (SMART) in patients with locally advanced pancreatic cancer (LAPC): GABRINOX-ART phase 2, multicenter trial
Portales, Fabienne
Ychou, Marc
Samalin, Emmanuelle
Assenat, Eric
Obled, Stephane
Tyran, Marguerite
Mitry, Emmanuel
Rouffiac, Magali
Ghiringhelli, Francois
Bachet, Jean-Baptiste
Simon, Jean-Marc
De Ridder, Mark
Fiess, Catherine
Moussion, Aurore
Delaine, Stephanie
Grigorescu, Florin
Gourgou, Sophie
Riou, Olivier
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[36] A Prospective, Single-Arm, Phase II, Multi-Center Study of Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Cancer
Olson, A. C.
Skiba, J. H.
Gill, B. S.
Wang, H.
Davies, B.
Holeva, K.
D'Ambrosio, D.
Wegner, R. E.
Heron, D. E.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E288 - E289
[37] Stereotactic MRI-guided Adaptive Radiation Therapy for Non-metastatic Pancreatic Cancer; Outcomes and Toxicity Analysis for Patients Treated in an Underserved Urban Center
Kirsch, Celina
Schaff, Eric
Parikh, Parag
Movsas, Benjamin
Siddiqui, Farzan
Kwon, David
Li, Pin
Khan, Gazala
Shah, Rupen
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2021, 44 (10): : S54 - S54
[38] Stereotactic Magnetic Resonance-guided Adaptive Radiation Therapy for Localized Kidney Cancer: Early Outcomes from a Prospective Phase 1 Trial and Supplemental Cohort
Yim, Kendrick
Hsu, Shu-Hui
Nolazco, Jose Ignacio
Cagney, Daniel
Mak, Raymond H.
D'Andrea, Vincent
Singer, Lisa
Williams, Christopher
Huynh, Elizabeth
Han, Zhaohui
Martin, Neil
Nguyen, Paul
Kibel, Adam S.
Choueiri, Toni K.
Chang, Steven L.
Leeman, Jonathan E.
EUROPEAN UROLOGY ONCOLOGY, 2024, 7 (01): : 147 - 150
[39] Surgical and Pathologic Outcomes in Patients on a Phase II Trial of Neoadjuvant Chemotherapy and Hypofractionated Image-Guided Intensity Modulated Radiation Therapy (HIGRT) in Resectable and Borderline Resectable Pancreatic Cancer
Stephens, S. J.
Czito, B.
Zhang, X.
Duffy, E.
Malicki, M.
Pitcher, B.
Niedzwiecki, D.
Abbruzzese, J.
Uronis, H.
Blobe, G.
Blazer, D. G.
Willett, C. G.
Palta, M.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : S180 - S180
[40] A phase I/II multi-center study of nivolumab and carboplatin/paclitaxel with radiation therapy (RT) for patients with locally advanced esophageal squamous cell carcinoma (ESCC).
Giuroiu, Iulia
Ku, Geoffrey Yuyat
Leichman, Lawrence P.
Du, Kevin Lee
Oh, Philmo
Levinson, Benjamin A.
Iqbal, Syma
Thomas, Charles R.
Wu, Jennifer J.
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)

← 1 2 3 4 5 →